GJ

Gaurav Jajoo

Active Director Director DIN 02018152
DIN 02018152 First appointment Mar 2005 Primary industry Consumer Goods
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2005
Shareholding value •••• Premium profile

About Gaurav Jajoo

Data last updated:

Gaurav Jajoo is a Director at Vyanktesh Pharma Private Limited (since 2005). The company operates in Consumer Goods. Vyanktesh Pharma Private Limited reported revenue of ₹40.7 Lakh (FY 2023).

DIN 02018152
Primary Designation Director
Industry Consumer Goods
First Appointment 24 Mar 2005
Oldest Company Age 21 yrs
Largest company Vyanktesh Pharma Private Limited · ₹40.7 Lakh (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Vyanktesh Pharma Private Limited U02423MP2005PTC017467
Director24 Mar 20052005₹40.7 Lakh (FY 2023)Active

Board colleagues of Gaurav Jajoo

Directorship timeline

Open interactive timeline →
Vyanktesh Pharma Private Limited
Premium access

Shareholding and investment profile for Gaurav Jajoo

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gaurav Jajoo

Gaurav Jajoo currently holds 1 directorship: Vyanktesh Pharma Private Limited (Director, since 24 Mar 2005, revenue ₹40.7 Lakh (FY 2023)).

Gaurav Jajoo was first appointed on 24 Mar 2005 as Director at Vyanktesh Pharma Private Limited.

The current boards of Gaurav Jajoo's companies include Govind Maheshwari (Vyanktesh Pharma Private Limited), Sunil Baheti (Vyanktesh Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available